Gemspring Capital’s portfolio company Zavation Medical Products has acquired US-based spinal implants provider CoreLink from the Stephens Group.

The Stephens Group will own a minority interest in the combined entity.

Zavation and CoreLink will continue to conduct operations under their respective brands.

Zavation CEO Jeffrey Johnson will lead the combined business, while CoreLink CEO Jay Bartling will serve as chairman of the board of directors.

Johnson said: “The combination of Zavation and CoreLink brings together two industry-leading businesses with shared values and customer-centric cultures.

“We remain dedicated to working with our distributor partners to deliver the highest quality spinal solutions for surgeons and patients across the country.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The combined company will be able to continue investing in new technologies and offer improved customer service to surgeons and distributor partners.

CoreLink offers new devices and instrumentation for spinal surgery along with a differentiated product portfolio that supports lateral spine procedures.

The company internally designs and manufactures over 99% of its spinal implant systems. It uses in-house additive manufacturing techniques to develop Mimetic Metal technology, which enables enhanced patient outcomes.

CoreLink also developed a modern Bioskills facility in St. Louis, Missouri, to meet growing surgical requirements.

Gemspring managing director Don Gerne said: “Through this transformative combination, Zavation and CoreLink will be able to provide an expanded product suite and enhanced capabilities to remain hyper-responsive to the needs of customers and partners across the country.”

The companies have not disclosed the terms of the deal.